DIAGNOSTIC CHALLENGES IN CREUTZFELDT-JAKOB DISEASE: A CASE STUDY

Authors

  • Elenara Barbosa Machado Neves Author
  • Grasiele Mattei Ise dos Santos Author
  • Vitória Mendonça Mendes Author
  • Lucas Mendes Tavares da Silveira Author
  • André Rausch Carellos Silva Author
  • Eduardo Dionathas Firmino Author
  • Juscelio Clemente de Abre Author
  • Monica Correa Author

DOI:

https://doi.org/10.56238/arev8n1-106

Keywords:

Creutzfeldt-Jakob Disease, Neurology, Clinical Management, Prion, Neurodegeneration, Differential Diagnosis, Electroencephalogram, RT-QuIC, Cognitive Decline

Abstract

Creutzfeldt-Jakob Disease (CJD) is a severe and rapidly progressive neurological disease, with a median survival of 6 to 12 months, caused by the abnormal accumulation of prion protein in the brain. It is characterized by rapid dementia, myoclonus, tremors, ataxia, and motor impairments. Due to its nonspecific clinical presentation, diagnosis is challenging and often delayed, but the association of clinical findings with complementary examinations, such as magnetic resonance imaging, cerebrospinal fluid analysis, and EEG, contributes to its early identification. This report describes the case of a 73-year-old male patient, previously healthy, residing in a rural area of ​​Minas Gerais, who presented with subacute onset of mental confusion, associated with rigidity, incoherent speech, stereotyped movements, and progressive loss of autonomy. Initially treated with antipsychotics and antidepressants without response, he was admitted to a tertiary hospital, where laboratory tests ruled out infections and metabolic disorders. Magnetic resonance imaging (MRI) revealed cortical hyperintensities in the right frontal, parietal, and occipital lobes, as well as involvement of the caudate nucleus, and cerebrospinal fluid analysis revealed positivity for the 14-3-3 protein, consistent with sporadic CJD. During the course of the disease, the patient presented with severe neurological deterioration, requiring prolonged care, and bilateral laminar subdural hemorrhage as an associated complication. Therefore, this case highlights the importance of comprehensive assessment in elderly patients with mental confusion, especially after intensive pharmacological treatments. The interaction between pre-existing neurological conditions, medication use, and metabolic factors should be carefully considered.

Downloads

Download data is not yet available.

References

APPLEBY, B. S.; MADDOX, R.; SCHONBERGER, L. B.; CALI, I.; HAMMETT, T.; COHEN, M.; BELAY, E. Sporadic Creutzfeldt-Jakob disease in a very young person. Neurology, v. 97, n. 17, p. 813–816, 2021.

BRASIL. Ministério da Saúde. Doença de Creutzfeldt-Jakob – DCJ. Brasília: Ministério da Saúde, [2020]. Disponível em: https://www.gov.br/saude/pt- br/assuntos/saude-de-a-a-z/d/dcj. Acesso em: 10 abr. 2025.

BRASIL. Conselho Nacional de Saúde. Resolução nº 466, de 12 de dezembro de 2012. Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União: seção 1, Brasília, DF, 13 jun. 2012.

FARNETANO, B. S.; LEÃO, C. N.; OLIVEIRA, I. N. F.; MACHARETH, M. M. V.; DAMACENO, R. A.; MOTA, G. S. M.; BRANDÃO, C. M.; ALMEIDA, H. T. Doença de Creutzfeldt-Jakob: relato de caso. Revista da Sociedade Brasileira de Clínica Médica, v. 17, n. 1, p. 31–34, 2019.

HADDAD, N. M.; MARZZANI, L. E.; OLIVEIRA, H. P.; CRUZ, T. F.; FRAINER, D. A.; WELTER, C. S.; ZALLI, M. Doença de Creutzfeldt-Jakob iniciando como um surto psicótico: um relato de caso. Arquivos Catarinenses de Medicina, v. 51, n. 4, p. 106– 112, 2022.

HALL, W. A.; MASOOD, W. Creutzfeldt-Jakob disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025. Atualizado em: 23 jun. 2025. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK507860/. Acesso em: 10 out. 2025.

HERMANN, P.; APPLEBY, B.; BRANDEL, J. P.; CAUGHEY, B.; COLLINS, S.; GESCHWIND, M. D.; GREEN, A.; HAÏK, S.; KOVACS, G. G.; LADOGANA, A.; LLORENS, F.; MEAD, S.; NISHIDA, N.; PAL, S.; PARCHI, P.; POCCHIARI, M.; SATOH, K.; ZANUSSO, G.; ZERR, I. Biomarkersanddiagnosticguidelines for sporadicCreutzfeldt-Jakob disease. The Lancet Neurology, v. 20, n. 3, p. 235-246, mar. 2021.

JURCAU, M. C.; JURCAU, A.; DIACONU, R. G.; HOGEA, V. O.; NUNKO, V. S. A systematic review of sporadic Creutzfeldt-Jakob disease: pathogenesis, diagnosis, and therapeutic attempts. Neurology International, v. 16, n. 5, p. 1039–1065, 2024.

MINISTÉRIO DA SAÚDE. Doença de Creutzfeldt-Jakob (DCJ). Brasília, DF: Ministério da Saúde, [s. d.]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/saude-de- a-a-z/d/dcj. Acesso em: 10 out. 2025.

MIRANDA, L. H. L.; OLIVEIRA, A. F. P. H.; CARVALHO, D. M.; SOUZA, G. M. F.; MAGALHÃES, J. G. M.; JÚNIOR, J. A. C.; LIMA, P. T. M. B. Q.; JÚNIOR, R. M. A.; FILHO, S. P. L.; MELO, H. M. A. Systematic review of pharmacological management in Creutzfeldt-Jakob disease: no options so far? Arquivos de Neuro-Psiquiatria, v. 80, n. 8, p. 837–844, 2022.

NOOR, H.; BAQAI, M. H.; NAVEED, H.; NAVEED, T.; REHMAN, S. S.; ASLAM, M. S.; LAKDAWALA, F. M.; MEMON, W. A.; RANI, S.; KHAN, H.; IMRAN, A.; FAROOQUI, S. K. Creutzfeldt-Jakob disease: A comprehensive review of current understanding and research. Journal of Neurological Sciences, v. 467, p. 123293, 15 dez. 2024.

OLIVEIRA, R.; DIAS, M.; MARQUES, I. B. Creutzfeldt-Jakob disease: atypical presentation of a very rare disease. Acta Médica Portuguesa, v. 34, n. 9, p. 619–623, 2021.

PARK, H. Y.; KIM, M.; SUH, C. H.; KIM, S. Y.; SHIM, W. H.; KIM, S. J. Diagnostic value of diffusion-weighted brain magnetic resonance imaging in patients with sporadic Creutzfeldt-Jakob disease: a systematic review and meta-analysis. European Radiology, v. 31, n. 12, p. 9073–9085, 2021.

RASHEED, U.; KHAN, S.; KHALID, M.; NOOR, A.; ZAFAR, S. A systemic analysis of CreutzfeldtJakob disease cases in Asia. Prion, v. 18, n. 1, p. 11–27, dez. 2024.

SAHYOUNI, M.; CASEY, B. 3rd; CARPENTER, Z.; ESTRELLA, F.; OKAFOR, C. Euphoric presentation in Creutzfeldt-Jakob disease and its diagnostic implications: a case report. Cureus, v. 16, n. 4, e57419, 2024.

SALEHI, P.; CLARK, M.; PINZON, J.; PATIL, A. Sporadic Creutzfeldt-Jakob disease.American Journal of Emergency Medicine, v. 52, p. 267.e1–267.e3, fev. 2022.

SATO, A. Creutzfeldt-Jakob Disease. No ShinkeiGeka, v. 49, n. 2, p. 407-412, mar. 2021.

SENESI, M.; LEWIS, V.; VARGHESE, S.; STEHMANN, C.; McGLADE, A.; DOECKE, J. D.; ELLETT, L.; SARROS, S.; FOWLER, C. J.; MASTERS, C. L.; LI, Q. X.; COLLINS, S. J. Diagnostic performance of CSF biomarkers in a well-characterized Australian cohort of sporadic Creutzfeldt-Jakob disease. Frontiers in Neurology, v. 14, 1072952, 2023.

SITAMMAGARI, K. K.; MASOOD, W. Creutzfeldt-Jakob disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021. Atualizado em: 6 mar. 2021. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK507860/. Acesso em: 10 out. 2025.

USLU, F. I.; ELIF, G.; GÜRSOY, A. E.; KOLUKISA, M.; YILDIZ, G. B. Creutzfeldt-Jakob Disease: A single center experience and systemic analysis of cases in Turkey. IdeggyógyászatiSzemle, v. 73, n. 05-06, p. 177–184, 30 maio 2020.

UTTLEY, L.; CARROLL, C.; WONG, R.; HILTON, D. A.; STEVENSON, M. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. The Lancet Infectious Diseases, v. 20, n. 1, p. e2–e10, 2020.

ZERR, I.; LADOGANA, A.; MEAD, S.; HERMANN, P.; FORLONI, G.; APPLEBY, B. S. Creutzfeldt-Jakob disease and other prion diseases. Nature Reviews Disease Primers, v. 10, n. 1, p. 14, 29 fev. 2024.

ZERR, I. Laboratory diagnosis of Creutzfeldt-Jakob disease.The New England Journal of Medicine, v. 386, n. 14, p. 1345-1350, 7 abr. 2022.

Published

2026-01-12

Issue

Section

Articles

How to Cite

NEVES, Elenara Barbosa Machado; DOS SANTOS, Grasiele Mattei Ise; MENDES, Vitória Mendonça; DA SILVEIRA, Lucas Mendes Tavares; SILVA, André Rausch Carellos; FIRMINO, Eduardo Dionathas; DE ABRE, Juscelio Clemente; CORREA, Monica. DIAGNOSTIC CHALLENGES IN CREUTZFELDT-JAKOB DISEASE: A CASE STUDY. ARACÊ , [S. l.], v. 8, n. 1, p. e11828, 2026. DOI: 10.56238/arev8n1-106. Disponível em: https://periodicos.newsciencepubl.com/arace/article/view/11828. Acesso em: 18 jan. 2026.